189 related articles for article (PubMed ID: 21657943)
1. Familial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution.
Liyanage KE; Burnett JR; Hooper AJ; van Bockxmeer FM
Crit Rev Clin Lab Sci; 2011; 48(1):1-18. PubMed ID: 21657943
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
3. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
Bourbon M; Rato Q;
Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
[TBL] [Abstract][Full Text] [Related]
4. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.
Austin MA; Hutter CM; Zimmern RL; Humphries SE
Am J Epidemiol; 2004 Sep; 160(5):407-20. PubMed ID: 15321837
[TBL] [Abstract][Full Text] [Related]
5. The extended abnormalities in lipoprotein metabolism in familial hypercholesterolemia: developing a new framework for future therapies.
Ooi EM; Barrett PH; Watts GF
Int J Cardiol; 2013 Oct; 168(3):1811-8. PubMed ID: 23907036
[TBL] [Abstract][Full Text] [Related]
6. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
7. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
[TBL] [Abstract][Full Text] [Related]
8. LDL-receptor mutations in Europe.
Dedoussis GV; Schmidt H; Genschel J
Hum Mutat; 2004 Dec; 24(6):443-59. PubMed ID: 15523646
[TBL] [Abstract][Full Text] [Related]
9. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
Fouchier SW; Kastelein JJ; Defesche JC
Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
[TBL] [Abstract][Full Text] [Related]
10. Familial defective apolipoprotein B-100.
Hansen PS
Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
[TBL] [Abstract][Full Text] [Related]
11. An APEX-based genotyping microarray for the screening of 168 mutations associated with familial hypercholesterolemia.
Dušková L; Kopečková L; Jansová E; Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
Atherosclerosis; 2011 May; 216(1):139-45. PubMed ID: 21310417
[TBL] [Abstract][Full Text] [Related]
12. Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.
Wang J; Huff E; Janecka L; Hegele RA
Hum Mutat; 2001 Oct; 18(4):359. PubMed ID: 11668627
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic children.
van der Graaf A; Avis HJ; Kusters DM; Vissers MN; Hutten BA; Defesche JC; Huijgen R; Fouchier SW; Wijburg FA; Kastelein JJ; Wiegman A
Circulation; 2011 Mar; 123(11):1167-73. PubMed ID: 21382890
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of coronary heart disease in familial hypercholesterolemia].
Miserez AR; Keller U
Ther Umsch; 1994 Oct; 51(10):671-6. PubMed ID: 7839323
[TBL] [Abstract][Full Text] [Related]
15. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations.
Dedoussis GV; Skoumas J; Pitsavos C; Choumerianou DM; Genschel J; Schmidt H; Stefanadis C
Eur J Clin Invest; 2004 Jun; 34(6):402-9. PubMed ID: 15200491
[TBL] [Abstract][Full Text] [Related]
16. Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred.
Takada D; Emi M; Ezura Y; Nobe Y; Kawamura K; Iino Y; Katayama Y; Xin Y; Wu LL; Larringa-Shum S; Stephenson SH; Hunt SC; Hopkins PN
J Hum Genet; 2002; 47(12):656-64. PubMed ID: 12522687
[TBL] [Abstract][Full Text] [Related]
17. Familial hypercholesterolemia and coronary heart disease: a HuGE association review.
Austin MA; Hutter CM; Zimmern RL; Humphries SE
Am J Epidemiol; 2004 Sep; 160(5):421-9. PubMed ID: 15321838
[TBL] [Abstract][Full Text] [Related]
18. Autosomal recessive hypercholesterolemia in three sisters with phenotypic homozygous familial hypercholesterolemia: diagnostic and therapeutic procedures.
Thomas HP; Vogt A; Wilund KR; Schliesser C; Steinhagen-Thiessen E; Kassner U
Ther Apher Dial; 2004 Aug; 8(4):275-80. PubMed ID: 15274677
[TBL] [Abstract][Full Text] [Related]
19. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
Real JT; Chaves FJ; Ejarque I; García-García AB; Valldecabres C; Ascaso JF; Armengod ME; Carmena R
Eur J Hum Genet; 2003 Dec; 11(12):959-65. PubMed ID: 14508510
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children.
Page MM; Bell DA; Hooper AJ; Watts GF; Burnett JR
Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):387-403. PubMed ID: 24840266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
